BCRX - BioCryst Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts9999
Avg. Estimate-0.32-0.3-1.24-1.03
Low Estimate-0.35-0.39-1.36-1.45
High Estimate-0.27-0.25-1.18-0.76
Year Ago EPS-0.28-0.25-0.98-1.24
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts8899
Avg. Estimate2.96M2.55M13.37M34.44M
Low Estimate900kN/A9.2M10M
High Estimate7M4.96M17M87M
Year Ago Sales1.45M2.73M20.65M13.37M
Sales Growth (year/est)103.60%-6.60%-35.30%157.60%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-0.26-0.25-0.27-0.31
EPS Actual-0.28-0.25-0.28-0.34
Difference-0.020-0.01-0.03
Surprise %-7.70%0.00%-3.70%-9.70%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.32-0.3-1.24-1.03
7 Days Ago-0.32-0.3-1.24-1.03
30 Days Ago-0.32-0.3-1.24-1.06
60 Days Ago-0.32-0.3-1.24-1.06
90 Days Ago-0.31-0.32-1.22-1.08
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/A1
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesBCRXIndustrySectorS&P 500
Current Qtr.-14.30%N/AN/A-0.02
Next Qtr.-20.00%N/AN/A0.07
Current Year-26.50%N/AN/A-0.02
Next Year16.90%N/AN/A0.14
Next 5 Years (per annum)19.90%N/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A